Latest Financial Results
FY 2019
Fiscal Year Ended Dec 31, 2019
Company Overview
SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by developing innovative therapies. The SCYNEXIS team has extensive experience in the life sciences industry, discovering and developing more than 30 innovative medicines over a broad range of therapeutic areas.
Stock Information
Symbol
Nasdaq: SCYXPrice
Change
Daily Volume
52-week Low/High
Day Low/High
Investor Contact Information
Investor Relations
LifeSci Advisors
Irina Koffler
T: 646-970-4681
ikoffler@lifesciadvisors.com
Media Relations
LifeSci Communications
Gloria Gasaatura
T: 646-970-4688
ggasaatura@lifescicomms.com
Transfer Agent
American Stock Transfer & Trust Company, LLC
10150 Mallard Creek Road
Suite 307
Charlotte, NC 28262
T: 800-937-5449